EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 13th, 2023 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
This EXECUTIVE EMPLOYMENT AGREEMENT dated as of January 1, 2023 (“Agreement”) is by and between RYAN FUKUSHIMA (“Executive”) and TEMPUS LABS, INC. (“Company”).
SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • November 13th, 2023 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • New York
This CREDIT AGREEMENT is entered into as of September 22, 2022, by and among TEMPUS LABS, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto from time to time, ARES CAPITAL CORPORATION, as Administrative Agent, and ARES CAPITAL MANAGEMENT LLC, as Lead Arranger and Bookrunner.
ELEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 13th, 2023 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
This ELEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of October 11, 2023, by and among Tempus Labs, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of whom is referred to in this Agreement as an “Investor” and each of the stockholders listed on Schedule B hereto, each of whom is referred to in this Agreement as a “Common Holder.”
Master AgreementSubscription Agreement • November 13th, 2023 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Illinois
This Master Agreement (inclusive of all Exhibits and Order Forms, the “Agreement”) is entered into by and between Tempus Labs, Inc. (on behalf of itself and its affiliates, “Tempus”), and Recursion Pharmaceutical, Inc. (“Client” or “Recursion”). Tempus and Recursion are each individually a “Party” and are collectively the “Parties.”
